Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblastsZhite Zhao, Changhong Shi, Xinglin He et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 13
Abstract 393: RAS and PI3K activation promote glioblastoma progression and ischemia-associated tumor cell deathSoo Yeon Kim, Wěi Li, Miaolu Tang et al.|Cancer Research|2024Cited by 0